Literature DB >> 3205717

An embryonic DNA-binding protein specific for a region of the human IFN beta 1 promoter.

A Haggarty1, A Ponton, G D Paterno, L Daigneault, D Skup.   

Abstract

Embryonal carcinoma (EC) cells are unable to make interferon in response to inducing agents. This block disappears after differentiation. We have found that nuclear extracts from undifferentiated P19 EC cells contain a DNA-binding activity which specifically recognizes a region within the human interferon-beta 1 promoter. This activity is absent from differentiated cell types, both of EC and non-EC origin. The binding of the factor in undifferentiated EC cells leads to dramatic changes in the overall protein binding pattern of the interferon promoter as compared with differentiated cells, and may be responsible for repression of the endogenous interferon-beta gene prior to differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3205717      PMCID: PMC338925          DOI: 10.1093/nar/16.22.10575

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  Expression of a chemically synthesized human alpha 1 interferon gene.

Authors:  E De Maeyer; D Skup; K S Prasad; J De Maeyer-Guignard; B Williams; P Meacock; G Sharpe; D Pioli; J Hennam; W Schuch; K Atherton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

2.  Inducer-responsive expression of the cloned human interferon beta 1 gene introduced into cultured mouse cells.

Authors:  S Ohno; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1982-02-11       Impact factor: 16.971

3.  Controlled transcription of a human alpha-interferon gene introduced into mouse L cells.

Authors:  N Mantei; C Weissmann
Journal:  Nature       Date:  1982-05-13       Impact factor: 49.962

4.  The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  Isolation of male embryonal carcinoma cells and their chromosome replication patterns.

Authors:  M W McBurney; B J Rogers
Journal:  Dev Biol       Date:  1982-02       Impact factor: 3.582

6.  Regulation of translation in L-cells infected with reovirus.

Authors:  D Skup; H Zarbl; S Millward
Journal:  J Mol Biol       Date:  1981-09-05       Impact factor: 5.469

7.  Delimitation and properties of DNA sequences required for the regulated expression of human interferon-beta gene.

Authors:  T Fujita; S Ohno; H Yasumitsu; T Taniguchi
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

8.  Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro.

Authors:  D C Burke; C F Graham; J M Lehman
Journal:  Cell       Date:  1978-02       Impact factor: 41.582

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Deletion mapping of the inducible promoter of human IFN-beta gene.

Authors:  J Tavernier; D Gheysen; F Duerinck; J Van der Heyden; W Fiers
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

View more
  3 in total

1.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

Authors:  J R Flanagan; M Murata; P A Burke; Y Shirayoshi; E Appella; P A Sharp; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Two distinct pathways of interferon induction as revealed by 2-aminopurine.

Authors:  L Daigneault; A Haggarty; Q H Meng; D Skup
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

3.  Control of beta-interferon expression in murine embryonal carcinoma F9 cells.

Authors:  M K Francis; J M Lehman
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.